Edwards Lifesciences Corporation (EW) Stake Lessened by Roosevelt Investment Group Inc.

Roosevelt Investment Group Inc. lowered its stake in shares of Edwards Lifesciences Corporation (NYSE:EW) by 5.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 118,752 shares of the medical research company’s stock after selling 6,535 shares during the quarter. Roosevelt Investment Group Inc. owned about 0.06% of Edwards Lifesciences Corporation worth $14,041,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. YorkBridge Wealth Partners LLC acquired a new position in shares of Edwards Lifesciences Corporation during the first quarter valued at about $110,000. NEXT Financial Group Inc increased its holdings in shares of Edwards Lifesciences Corporation by 91.7% during the first quarter. NEXT Financial Group Inc now owns 1,045 shares of the medical research company’s stock valued at $115,000 after acquiring an additional 500 shares in the last quarter. Shine Investment Advisory Services Inc. acquired a new position in shares of Edwards Lifesciences Corporation during the second quarter valued at about $126,000. Cornerstone Advisors Inc. increased its holdings in shares of Edwards Lifesciences Corporation by 25.1% during the second quarter. Cornerstone Advisors Inc. now owns 1,092 shares of the medical research company’s stock valued at $129,000 after acquiring an additional 219 shares in the last quarter. Finally, Alexandria Capital LLC increased its holdings in shares of Edwards Lifesciences Corporation by 1.7% during the second quarter. Alexandria Capital LLC now owns 1,146 shares of the medical research company’s stock valued at $136,000 after acquiring an additional 19 shares in the last quarter. Hedge funds and other institutional investors own 82.36% of the company’s stock.

Shares of Edwards Lifesciences Corporation (NYSE:EW) traded down 0.10% on Tuesday, hitting $115.01. The stock had a trading volume of 360,053 shares. The firm has a 50 day moving average of $114.35 and a 200 day moving average of $108.51. The stock has a market cap of $24.29 billion, a P/E ratio of 34.88 and a beta of 0.64. Edwards Lifesciences Corporation has a 12 month low of $81.12 and a 12 month high of $121.75.

Edwards Lifesciences Corporation (NYSE:EW) last announced its quarterly earnings data on Wednesday, July 26th. The medical research company reported $1.08 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.88 by $0.20. Edwards Lifesciences Corporation had a return on equity of 27.17% and a net margin of 22.16%. The firm had revenue of $842.00 million for the quarter, compared to analyst estimates of $839.16 million. During the same quarter in the prior year, the company posted $0.76 earnings per share. Edwards Lifesciences Corporation’s quarterly revenue was up 10.9% on a year-over-year basis. On average, equities analysts forecast that Edwards Lifesciences Corporation will post $3.78 earnings per share for the current fiscal year.

In related news, VP Catherine M. Szyman sold 4,681 shares of the company’s stock in a transaction on Monday, July 31st. The stock was sold at an average price of $115.78, for a total transaction of $541,966.18. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Michael A. Mussallem sold 32,900 shares of the company’s stock in a transaction on Monday, July 31st. The stock was sold at an average price of $114.80, for a total value of $3,776,920.00. The disclosure for this sale can be found here. Insiders have sold 163,541 shares of company stock worth $18,712,719 in the last ninety days. 2.13% of the stock is currently owned by corporate insiders.

TRADEMARK VIOLATION WARNING: “Edwards Lifesciences Corporation (EW) Stake Lessened by Roosevelt Investment Group Inc.” was posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this piece can be accessed at https://sportsperspectives.com/2017/09/12/edwards-lifesciences-corporation-ew-stake-lessened-by-roosevelt-investment-group-inc.html.

EW has been the topic of several recent analyst reports. BidaskClub upgraded shares of Edwards Lifesciences Corporation from a “buy” rating to a “strong-buy” rating in a report on Thursday, June 22nd. BMO Capital Markets restated a “buy” rating and set a $132.00 price objective on shares of Edwards Lifesciences Corporation in a report on Friday, September 1st. Zacks Investment Research upgraded shares of Edwards Lifesciences Corporation from a “hold” rating to a “buy” rating and set a $130.00 price objective on the stock in a report on Tuesday, July 18th. Cowen and Company restated an “outperform” rating and set a $135.00 price objective (up previously from $130.00) on shares of Edwards Lifesciences Corporation in a report on Thursday, July 27th. Finally, Jefferies Group LLC restated a “buy” rating and set a $115.00 price objective on shares of Edwards Lifesciences Corporation in a report on Friday, June 30th. Six equities research analysts have rated the stock with a hold rating, sixteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. Edwards Lifesciences Corporation currently has an average rating of “Buy” and an average target price of $120.75.

Edwards Lifesciences Corporation Profile

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient’s diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World.

Institutional Ownership by Quarter for Edwards Lifesciences Corporation (NYSE:EW)

Receive News & Ratings for Edwards Lifesciences Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edwards Lifesciences Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply